Home ›› Tools ›› Author Institution Mapping

Select the journal to see authorsí institution mapping (AIM) for the latest issue
Select journal
Asian Journal of Andrology

Table of Contents RSS Feed
2016| July-August  | Volume 18 | Issue 4  

Please wait, loading Google Map...

Translation of genomics and epigenomics in prostate cancer: progress and promising directions p. 503
Wennuan Liu, Jianfeng Xu
[ABSTRACT]  [HTML Full text]  [PDF]
Personalized prostate cancer care: from screening to treatment p. 505
Carly A Conran, Charles B Brendler, Jianfeng Xu
[ABSTRACT]  [HTML Full text]  [PDF]
Clinical validity and utility of genetic risk scores in prostate cancer p. 509
Brian T Helfand, James Kearns, Carly Conran, Jianfeng Xu
[ABSTRACT]  [HTML Full text]  [PDF]
A comparison of genetic risk score with family history for estimating prostate cancer risk p. 515
Brian T Helfand
[ABSTRACT]  [HTML Full text]  [PDF]
Population-standardized genetic risk score: the SNP-based method of choice for inherited risk assessment of prostate cancer p. 520
Carly A Conran, Rong Na, Haitao Chen, Deke Jiang, Xiaoling Lin, S Lilly Zheng, Charles B Brendler, Jianfeng Xu
[ABSTRACT]  [HTML Full text]  [PDF]
Race-specific genetic risk score is more accurate than nonrace-specific genetic risk score for predicting prostate cancer and high-grade diseases p. 525
Rong Na, Dingwei Ye, Jun Qi, Fang Liu, Xiaoling Lin, Brian T Helfand, Charles B Brendler, Carly Conran, Jian Gong, Yishuo Wu, Xu Gao, Yaqing Chen, S Lilly Zheng, Zengnan Mo, Qiang Ding, Yinghao Sun, Jianfeng Xu
[ABSTRACT]  [HTML Full text]  [PDF]
HOXB13 and other high penetrant genes for prostate cancer p. 530
Patrick G Pilie, Veda N Giri, Kathleen A Cooney
[ABSTRACT]  [HTML Full text]  [PDF]
DNA alterations in the tumor genome and their associations with clinical outcome in prostate cancer p. 533
Wennuan Liu
[ABSTRACT]  [HTML Full text]  [PDF]
Clinical variability and molecular heterogeneity in prostate cancer p. 543
Jonathan Shoag, Christopher E Barbieri
[ABSTRACT]  [HTML Full text]  [PDF]
Prostate cancer epigenetics and its clinical implications p. 549
Srinivasan Yegnasubramanian
[ABSTRACT]  [HTML Full text]  [PDF]
MicroRNA expression and function in prostate cancer: a review of current knowledge and opportunities for discovery p. 559
Binod Kumar, Shawn E Lupold
[ABSTRACT]  [HTML Full text]  [PDF]
Long noncoding RNAs in prostate cancer: overview and clinical implications p. 568
Bhavna Malik, Felix Y Feng
[ABSTRACT]  [HTML Full text]  [PDF]
Clinically available RNA profiling tests of prostate tumors: utility and comparison p. 575
Rong Na, Yishuo Wu, Qiang Ding, Jianfeng Xu
[ABSTRACT]  [HTML Full text]  [PDF]
Development of AR-V7 as a putative treatment selection marker for metastatic castration-resistant prostate cancer p. 580
Jun Luo
[ABSTRACT]  [HTML Full text]  [PDF]
Genomic predictors for treatment of late stage prostate cancer p. 586
Daniel H Shevrin
[ABSTRACT]  [HTML Full text]  [PDF]
The promising role of poly(ADP-ribose) polymerase inhibitors in prostate cancer p. 592
Jeanny B Aragon-Ching
[ABSTRACT]  [HTML Full text]  [PDF]
Two paths for stabilization of ERG in prostate carcinogenesis: TMPRSS2-ERG fusions and speckle-type pox virus and zinc finger protein mutations p. 594
Laura E Pascal, Zhou Wang
[ABSTRACT]  [HTML Full text]  [PDF]
Air quality control in the ART laboratory is a major determinant of IVF success p. 596
Sandro C Esteves, Fabiola C Bento
[ABSTRACT]  [HTML Full text]  [PDF]
Interaction between basigin and monocarboxylate transporter 2 in the mouse testes and spermatozoa p. 600
Cheng Chen, Mamiko Maekawa, Kenji Yamatoya, Masami Nozaki, Chizuru Ito, Toshihiko Iwanaga, Kiyotaka Toshimori
[ABSTRACT]  [HTML Full text]  [PDF]
Berberine inhibits androgen synthesis by interaction with aldo-keto reductase 1C3 in 22Rv1 prostate cancer cells p. 607
Yuantong Tian, Lijing Zhao, Ye Wang, Haitao Zhang, Duo Xu, Xuejian Zhao, Yi Li, Jing Li
[ABSTRACT]  [HTML Full text]  [PDF]
Effects of velvet antler polypeptide on sexual behavior and testosterone synthesis in aging male mice p. 613
Zhi-Jun Zang, Hong-Feng Tang, Ying Tuo, Wei-Jie Xing, Su-Yun Ji, Yong Gao, Chun-Hua Deng
[ABSTRACT]  [HTML Full text]  [PDF]
Claudin-11 and occludin are major contributors to Sertoli cell tight junction function, in vitro p. 620
Mark J McCabe, Caroline FH Foo, Marcel E Dinger, Peter M Smooker, Peter G Stanton
[ABSTRACT]  [HTML Full text]  [PDF]
Potential role of punicalagin against oxidative stress induced testicular damage p. 627
Faiza Rao, Hui Tian, Wenqing Li, Helong Hung, Fei Sun
[ABSTRACT]  [HTML Full text]  [PDF]
Performance of the Prostate Health Index in predicting prostate biopsy outcomes among men with a negative digital rectal examination and transrectal ultrasonography p. 633
Guo-Peng Yu, Rong Na, Ding-Wei Ye, Jun Qi, Fang Liu, Hai-Tao Chen, Yi-Shuo Wu, Gui-Ming Zhang, Jie-Lin Sun, Yao Zhu, Li-Qun Huang, Shan-Cheng Ren, De-Ke Jiang, S Lilly Zheng, Hao-Wen Jiang, Ying-Hao Sun, Qiang Ding, Jianfeng Xu
[ABSTRACT]  [HTML Full text]  [PDF]
Low serum testosterone predicts upgrading and upstaging of prostate cancer after radical prostatectomy p. 639
Yuan Gao, Chen-Yi Jiang, Shi-Kui Mao, Di Cui, Kui-Yuan Hao, Wei Zhao, Qi Jiang, Yuan Ruan, Shu-Jie Xia, Bang-Min Han
[ABSTRACT]  [HTML Full text]  [PDF]
Serum sex hormone and growth arrest-specific protein 6 levels in male patients with coronary heart disease p. 644
Rui Zhao, Yan Li, Wen Dai
[ABSTRACT]  [HTML Full text]  [PDF]
The presence of human papillomavirus and Epstein-Barr virus in male Chinese lichen sclerosus patients: a single center study p. 650
Yumeng Zhang, Qiang Fu, Xiong Zhang
[ABSTRACT]  [HTML Full text]  [PDF]
Autophagy: a stumbling block of androgen inhibition to treat benign prostatic hyperplasia or prostate cancer p. 654
Li Zhang, Jun Zhou, Song Fan, Chao-Zhao Liang
[ABSTRACT]  [HTML Full text]  [PDF]